Huaqiang Zhou
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 15
- Lung Cancer Research Studies 12
- Pancreatic and Hepatic Oncology Research 6
- Otorhinolaryngology top 5%
- Cancer Research top 10%
- Health Informatics top 10%
-
- Lung Cancer Treatments and Mutations 19
-
- Neuroendocrine Tumor Research Advances 9
-
- Genetic Associations and Epidemiology 6
- BRCA gene mutations in cancer 5
-
- RNA modifications and cancer 6
- Journals
- Annals of Oncology (8 papers)Journal of Thoracic Oncology (6 papers)Annals of Translational Medicine (5 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Huaqiang Zhou
64 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 106
- Oncology 529
- Otorhinolaryngology 69
- Cancer Research 206
- Health Informatics 15
- Pulmonary and Respiratory Medicine 344
Countries citing papers authored by Huaqiang Zhou
This map shows the geographic impact of Huaqiang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaqiang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaqiang Zhou more than expected).
Fields of papers citing papers by Huaqiang Zhou
This network shows the impact of papers produced by Huaqiang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaqiang Zhou. The network helps show where Huaqiang Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huaqiang Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 52 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 36 | |
| 11 | 2020 | 9 | |
| 12 | 2019 | 139 | |
| 13 | 2019 | 24 | |
| 14 | 2019 | 1 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 12 | |
| 17 | 2018 | 25 | |
| 18 | 2018 | 39 | |
| 19 | 2018 | 1 | |
| 20 | 2018 | 41 |
About Huaqiang Zhou
Huaqiang Zhou is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Cancer Immunotherapy and Biomarkers (15 papers), Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (9 papers), Pancreatic and Hepatic Oncology Research (6 papers), Genetic Associations and Epidemiology (6 papers), RNA modifications and cancer (6 papers) and BRCA gene mutations in cancer (5 papers). The work is most often cited by research in Oncology (529 citations), Otorhinolaryngology (69 citations) and Cancer Research (206 citations). Huaqiang Zhou has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Yaxiong Zhang, Zeting Qiu, Yan Huang, Yunpeng Yang, Li Zhang, Shaowei Gao, Wenfeng Fang, Shaodong Hong, Wulin Tan and Hongyun Zhao. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Annals of Translational Medicine, Cancer Medicine and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.